| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oligodendroglia | 11 | 2013 | 107 | 1.530 |
Why?
|
| Acetylcysteine | 4 | 2008 | 296 | 0.750 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 10 | 2013 | 133 | 0.720 |
Why?
|
| Central Nervous System | 5 | 2013 | 107 | 0.670 |
Why?
|
| Lovastatin | 10 | 2013 | 78 | 0.610 |
Why?
|
| Leukodystrophy, Globoid Cell | 2 | 2014 | 27 | 0.590 |
Why?
|
| Stem Cells | 6 | 2011 | 248 | 0.560 |
Why?
|
| S-Nitrosoglutathione | 2 | 2016 | 87 | 0.520 |
Why?
|
| Neuroglia | 5 | 2014 | 136 | 0.510 |
Why?
|
| Calcitriol | 2 | 2014 | 106 | 0.490 |
Why?
|
| Lipopolysaccharides | 5 | 2008 | 455 | 0.460 |
Why?
|
| Cholecalciferol | 1 | 2014 | 143 | 0.450 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2012 | 5 | 0.430 |
Why?
|
| Nitric Oxide Donors | 1 | 2012 | 54 | 0.420 |
Why?
|
| Cell Differentiation | 6 | 2013 | 1034 | 0.420 |
Why?
|
| PPAR alpha | 2 | 2013 | 31 | 0.420 |
Why?
|
| Cells, Cultured | 11 | 2014 | 2673 | 0.410 |
Why?
|
| Neuroprotective Agents | 4 | 2016 | 317 | 0.400 |
Why?
|
| Brain | 3 | 2016 | 2176 | 0.390 |
Why?
|
| Peroxisomes | 3 | 2008 | 48 | 0.390 |
Why?
|
| Rats | 17 | 2013 | 5300 | 0.380 |
Why?
|
| Animals, Newborn | 6 | 2014 | 396 | 0.370 |
Why?
|
| Peroxisomal Disorders | 2 | 2007 | 16 | 0.370 |
Why?
|
| Interleukin-17 | 1 | 2011 | 62 | 0.360 |
Why?
|
| Free Radical Scavengers | 2 | 2008 | 112 | 0.360 |
Why?
|
| Astrocytes | 1 | 2012 | 270 | 0.360 |
Why?
|
| Oxidative Stress | 2 | 2011 | 718 | 0.330 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 1293 | 0.320 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2008 | 57 | 0.320 |
Why?
|
| Phospholipids | 1 | 2008 | 108 | 0.310 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2011 | 626 | 0.310 |
Why?
|
| Animals | 26 | 2021 | 20881 | 0.310 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2013 | 212 | 0.300 |
Why?
|
| Cytokines | 8 | 2014 | 866 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2016 | 2083 | 0.270 |
Why?
|
| PPAR gamma | 3 | 2012 | 95 | 0.250 |
Why?
|
| Nerve Degeneration | 2 | 2008 | 134 | 0.250 |
Why?
|
| Inflammation | 5 | 2012 | 1030 | 0.250 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2004 | 4 | 0.250 |
Why?
|
| Apoptosis | 1 | 2011 | 1641 | 0.230 |
Why?
|
| Disease Models, Animal | 11 | 2016 | 2550 | 0.220 |
Why?
|
| rho-Associated Kinases | 2 | 2013 | 32 | 0.210 |
Why?
|
| Multiple Sclerosis | 4 | 2009 | 132 | 0.210 |
Why?
|
| Cell Survival | 4 | 2013 | 901 | 0.200 |
Why?
|
| Receptors, Atrial Natriuretic Factor | 1 | 2021 | 11 | 0.200 |
Why?
|
| Myelin Basic Protein | 3 | 2014 | 62 | 0.200 |
Why?
|
| Pulmonary Surfactants | 1 | 2021 | 41 | 0.200 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2021 | 28 | 0.190 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2013 | 19 | 0.190 |
Why?
|
| Reactive Oxygen Species | 4 | 2013 | 499 | 0.190 |
Why?
|
| Steroids | 1 | 2021 | 84 | 0.190 |
Why?
|
| Signal Transduction | 4 | 2013 | 2689 | 0.180 |
Why?
|
| RNA, Small Interfering | 3 | 2021 | 434 | 0.180 |
Why?
|
| Rats, Inbred Lew | 9 | 2013 | 150 | 0.180 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2010 | 49 | 0.170 |
Why?
|
| Oxygen | 1 | 2021 | 386 | 0.170 |
Why?
|
| Brain Injuries | 2 | 2016 | 268 | 0.170 |
Why?
|
| Mice | 10 | 2021 | 8474 | 0.170 |
Why?
|
| Rolipram | 2 | 2009 | 9 | 0.160 |
Why?
|
| Pregnancy | 4 | 2013 | 2334 | 0.160 |
Why?
|
| Orthoreovirus, Mammalian | 3 | 2003 | 7 | 0.160 |
Why?
|
| Reoviridae Infections | 3 | 2003 | 10 | 0.160 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2008 | 710 | 0.150 |
Why?
|
| Galactosylceramidase | 2 | 2014 | 11 | 0.150 |
Why?
|
| Vitamin D3 24-Hydroxylase | 2 | 2014 | 24 | 0.150 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 2 | 2014 | 21 | 0.150 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2013 | 48 | 0.150 |
Why?
|
| Demyelinating Diseases | 3 | 2008 | 57 | 0.150 |
Why?
|
| Analysis of Variance | 3 | 2013 | 1040 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 71 | 0.140 |
Why?
|
| Drug Interactions | 2 | 2007 | 289 | 0.130 |
Why?
|
| Glutathione | 2 | 2014 | 343 | 0.130 |
Why?
|
| Age Factors | 2 | 2014 | 1864 | 0.130 |
Why?
|
| Drug Synergism | 3 | 2011 | 260 | 0.130 |
Why?
|
| Lung | 4 | 2021 | 849 | 0.120 |
Why?
|
| Cell Line | 3 | 2021 | 1752 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2012 | 134 | 0.120 |
Why?
|
| Mice, Mutant Strains | 1 | 2014 | 166 | 0.120 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2013 | 93 | 0.120 |
Why?
|
| Myelin Sheath | 3 | 2013 | 115 | 0.120 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 149 | 0.120 |
Why?
|
| Transfection | 3 | 2013 | 782 | 0.110 |
Why?
|
| Metformin | 2 | 2013 | 63 | 0.110 |
Why?
|
| Recovery of Function | 1 | 2016 | 506 | 0.110 |
Why?
|
| Psychosine | 1 | 2013 | 33 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 2012 | 382 | 0.110 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2012 | 92 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2012 | 226 | 0.100 |
Why?
|
| RNA, Messenger | 4 | 2021 | 1664 | 0.100 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2012 | 37 | 0.100 |
Why?
|
| Female | 17 | 2013 | 38074 | 0.100 |
Why?
|
| Glucocorticoids | 3 | 2021 | 222 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 1745 | 0.100 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2009 | 28 | 0.100 |
Why?
|
| Coculture Techniques | 2 | 2010 | 147 | 0.100 |
Why?
|
| Growth Inhibitors | 1 | 2011 | 33 | 0.090 |
Why?
|
| DNA Primers | 2 | 2008 | 302 | 0.090 |
Why?
|
| Acyltransferases | 2 | 2007 | 40 | 0.090 |
Why?
|
| Mice, Knockout | 3 | 2013 | 1692 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2010 | 108 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2013 | 160 | 0.090 |
Why?
|
| Immunologic Factors | 2 | 2009 | 87 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2008 | 244 | 0.080 |
Why?
|
| Flow Cytometry | 2 | 2007 | 489 | 0.080 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 42 | 0.080 |
Why?
|
| Malondialdehyde | 1 | 2008 | 43 | 0.080 |
Why?
|
| Lipid Peroxidation | 1 | 2008 | 94 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 196 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2008 | 254 | 0.080 |
Why?
|
| Time Factors | 2 | 2007 | 4655 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2008 | 160 | 0.080 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2008 | 35 | 0.080 |
Why?
|
| Placenta | 1 | 2008 | 101 | 0.080 |
Why?
|
| Vitamin D | 1 | 2012 | 516 | 0.080 |
Why?
|
| Encephalitis | 1 | 2008 | 43 | 0.080 |
Why?
|
| Fetus | 1 | 2007 | 157 | 0.070 |
Why?
|
| Ribonucleotides | 1 | 2006 | 26 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2007 | 765 | 0.070 |
Why?
|
| Aminoimidazole Carboxamide | 1 | 2006 | 25 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2007 | 154 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 447 | 0.070 |
Why?
|
| Interleukin-4 | 1 | 2006 | 69 | 0.070 |
Why?
|
| Wound Healing | 1 | 2008 | 260 | 0.070 |
Why?
|
| Methylprednisolone | 2 | 2003 | 99 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 1174 | 0.060 |
Why?
|
| Humans | 10 | 2021 | 68618 | 0.060 |
Why?
|
| O Antigens | 1 | 2004 | 6 | 0.060 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 2004 | 18 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2004 | 17 | 0.060 |
Why?
|
| Pulmonary Fibrosis | 2 | 2003 | 157 | 0.060 |
Why?
|
| CD11b Antigen | 1 | 2004 | 47 | 0.060 |
Why?
|
| Antigens | 1 | 2004 | 90 | 0.060 |
Why?
|
| Cell Count | 1 | 2004 | 248 | 0.060 |
Why?
|
| Anticholesteremic Agents | 1 | 2004 | 49 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2004 | 103 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 176 | 0.060 |
Why?
|
| NADPH Oxidases | 1 | 2004 | 80 | 0.060 |
Why?
|
| NF-kappa B | 1 | 2006 | 432 | 0.060 |
Why?
|
| Cryptogenic Organizing Pneumonia | 1 | 2003 | 5 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2007 | 1553 | 0.060 |
Why?
|
| Cell Death | 1 | 2004 | 329 | 0.060 |
Why?
|
| Transcription Factors | 2 | 2004 | 753 | 0.060 |
Why?
|
| Th1 Cells | 3 | 2009 | 101 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 362 | 0.060 |
Why?
|
| Spinal Cord | 3 | 2012 | 244 | 0.050 |
Why?
|
| Drug Therapy, Combination | 3 | 2009 | 649 | 0.050 |
Why?
|
| Terbutaline | 1 | 2021 | 23 | 0.050 |
Why?
|
| Survival Rate | 1 | 2004 | 1056 | 0.050 |
Why?
|
| Betamethasone | 1 | 2021 | 24 | 0.050 |
Why?
|
| Body Fluids | 1 | 2021 | 41 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2021 | 54 | 0.050 |
Why?
|
| Sheep | 1 | 2021 | 128 | 0.050 |
Why?
|
| Infant | 1 | 2007 | 2891 | 0.050 |
Why?
|
| Dexamethasone | 1 | 2021 | 150 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2007 | 3187 | 0.050 |
Why?
|
| Mevalonic Acid | 2 | 2012 | 27 | 0.050 |
Why?
|
| Lipid Metabolism | 2 | 2013 | 186 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 597 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2004 | 902 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2004 | 2455 | 0.040 |
Why?
|
| Mice, Inbred CBA | 3 | 2003 | 107 | 0.040 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2003 | 117 | 0.040 |
Why?
|
| Th2 Cells | 2 | 2008 | 48 | 0.040 |
Why?
|
| Models, Biological | 1 | 2021 | 981 | 0.040 |
Why?
|
| Protein Stability | 1 | 2016 | 90 | 0.030 |
Why?
|
| Motor Skills | 1 | 2016 | 88 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 442 | 0.030 |
Why?
|
| Gene Expression | 1 | 2016 | 770 | 0.030 |
Why?
|
| Galactosides | 1 | 2013 | 5 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2013 | 67 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2016 | 384 | 0.030 |
Why?
|
| Galactosylceramides | 1 | 2013 | 12 | 0.030 |
Why?
|
| Central Nervous System Agents | 1 | 2013 | 37 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2013 | 351 | 0.030 |
Why?
|
| Steroid Hydroxylases | 1 | 2012 | 19 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 282 | 0.030 |
Why?
|
| Biosynthetic Pathways | 1 | 2012 | 15 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 2012 | 124 | 0.030 |
Why?
|
| Lymphoid Tissue | 1 | 2012 | 30 | 0.030 |
Why?
|
| Biological Availability | 1 | 2012 | 79 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 209 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2008 | 1174 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2013 | 261 | 0.030 |
Why?
|
| RNA Interference | 1 | 2013 | 266 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 1851 | 0.020 |
Why?
|
| Fibrosis | 2 | 2003 | 371 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 954 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 415 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 659 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 331 | 0.020 |
Why?
|
| Male | 2 | 2016 | 37321 | 0.020 |
Why?
|
| Wallerian Degeneration | 1 | 2009 | 6 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2009 | 93 | 0.020 |
Why?
|
| Cyclic AMP | 1 | 2009 | 223 | 0.020 |
Why?
|
| Polyisoprenyl Phosphates | 1 | 2008 | 8 | 0.020 |
Why?
|
| Methionine | 1 | 2008 | 36 | 0.020 |
Why?
|
| Hydroxymethylglutaryl CoA Reductases | 1 | 2008 | 17 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2008 | 114 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 2008 | 75 | 0.020 |
Why?
|
| Neurons | 1 | 2013 | 881 | 0.020 |
Why?
|
| ras Proteins | 1 | 2008 | 102 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 199 | 0.020 |
Why?
|
| Benzamides | 1 | 2008 | 156 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2006 | 50 | 0.020 |
Why?
|
| Cholesterol | 1 | 2008 | 331 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 2006 | 13 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 137 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2006 | 201 | 0.020 |
Why?
|
| Protein Transport | 1 | 2006 | 280 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2006 | 226 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 223 | 0.020 |
Why?
|
| Freund's Adjuvant | 1 | 2004 | 7 | 0.020 |
Why?
|
| Acyl-CoA Oxidase | 1 | 2004 | 12 | 0.020 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2004 | 14 | 0.020 |
Why?
|
| Picornaviridae Infections | 1 | 2004 | 2 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2006 | 247 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2006 | 791 | 0.020 |
Why?
|
| Genes, MHC Class II | 1 | 2004 | 29 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2004 | 83 | 0.010 |
Why?
|
| Microarray Analysis | 1 | 2004 | 63 | 0.010 |
Why?
|
| Catalase | 1 | 2004 | 85 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2009 | 1330 | 0.010 |
Why?
|
| Growth Substances | 1 | 2004 | 77 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 331 | 0.010 |
Why?
|
| Leukapheresis | 1 | 2003 | 8 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2006 | 481 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2004 | 120 | 0.010 |
Why?
|
| Fatty Acids | 1 | 2004 | 222 | 0.010 |
Why?
|
| Adult | 1 | 2021 | 21403 | 0.010 |
Why?
|
| Nasal Cavity | 1 | 2003 | 62 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 320 | 0.010 |
Why?
|
| Chemokines | 1 | 2003 | 119 | 0.010 |
Why?
|
| Base Sequence | 1 | 2004 | 1015 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 2791 | 0.010 |
Why?
|
| Cell Movement | 1 | 2005 | 630 | 0.010 |
Why?
|
| Hydroxyproline | 1 | 2002 | 33 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2002 | 32 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2002 | 149 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2002 | 69 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 682 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2003 | 266 | 0.010 |
Why?
|
| RNA | 1 | 2002 | 171 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2002 | 91 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 507 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 617 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 658 | 0.010 |
Why?
|
| Collagen | 1 | 2002 | 636 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2009 | 7029 | 0.010 |
Why?
|